Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 612 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: iron Clear all

Conditions: Anemia
Interventions: Ferric Carboxymaltose (FCM); Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Abnormal Uterine Bleeding
Interventions: Blood management, Usual care; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Pediatric Iron Deficiency, Anemia
Interventions: choline bitartrate, placebo drug; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 5 Months to 7 Months
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Colorectal Cancer
Interventions: Ferumoxytol, Magnetic Resonance Imaging; Drug · Other
Lead sponsor: Scott Potenta, MD, PhD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Papillary Carcinoma of Thyroid Gland, Metastatic Medullary Thyroid Cancer, Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Ferumoxytol, Nanoparticle MRI; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Iron-deficiency, Iron Deficiency Anemia, Iron Deficiency Anemia Treatment
Interventions: Iron supplement with a lunch meal containing beef, Iron supplement with a lunch meal containing plant-based alternative; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Functional Iron Deficiency, Trauma, Anemia
Interventions: Iron sucrose, Oxandrolone, IV iron placebo, Oxandrolone placebo; Drug
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Sickle Cell Disease, Thalassemia, Diamond-Blackfan Anemia
Interventions: Not listed
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 16 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Oakland, California

Conditions: Iron Deficiency
Interventions: Iron-dextran, Saline, Blood Donation, 24-hour PTR; Drug · Procedure
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Iron-deficiency, Iron Deficiency Anemia
Interventions: Meal; Other
Lead sponsor: Florida State University; Other
Eligibility: Not listed
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Womens Health, Menstrual Symptoms
Interventions: Effera® (human equivalent lactoferrin), Placebo; Dietary Supplement · Other
Lead sponsor: Helaina Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Anemia, Iron-Deficiency
Interventions: Iron sucrose, Epoetin Alfa, Blood Transfusion; Drug · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 80 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Pancreatic Cancer
Interventions: Superparamagnetic Iron Oxide Magnetic Resonance Imaging; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Iron-deficiency, Pregnancy Anemia, Obesity
Interventions: Jarrow Formulas Oral Bovine Lactoferrin Supplement; Dietary Supplement
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Non-transfusion Dependent Thalassemia
Interventions: deferasirox, placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 10 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: Oakland, California • Chicago, Illinois • New York, New York

Conditions: Chronic Kidney Diseases, Iron Deficiency Anemia
Interventions: KRX-0502; Drug
Lead sponsor: Keryx Biopharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 28
States / cities: Phoenix, Arizona • Chula Vista, California • El Centro, California + 23 more

Conditions: Iron Deficiency Anemia
Interventions: ferumoxytol; Drug
Lead sponsor: Dialysis Clinic, Inc.; Industry
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: North Brunswick, New Jersey

Conditions: Epilepsy
Interventions: Ferumoxytol injection after focal epileptic seizure followed by iron-sensitive MRI; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Bioequivalance
Interventions: Iron Sucrose Injection, Venofer Injection; Drug
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Heart Failure, Iron-deficiency
Interventions: IV Iron Infusion Group; Drug
Lead sponsor: Radha Gopalan; Other
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Hypertension
Interventions: nitroprusside, placebo infusion; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 1 Day to 17 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 8
States / cities: Little Rock, Arkansas • Stanford, California • Louisville, Kentucky + 4 more

Conditions: Iron Overload
Interventions: Serum Ferritin level, Serum Ferritin iron content, Urine Ferritin level, Urine ferritin iron content; Diagnostic Test
Lead sponsor: University of Utah; Other
Eligibility: 1 Year to 17 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Iron Metabolism Disorders
Interventions: observation; Other
Lead sponsor: Victor Gordeuk; Other
Eligibility: 25 Years to 44 Years · Female only
Enrollment: 22,042 participants
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Women, Sympathetic Nervous System, Aging, Blood Flow
Interventions: Norepinephrine, Isoproterenol, Acetylcholine, Nitroprusside, Estrogen; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Columbia, Missouri

Search by objective public record fields.

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Role of Blood Management in Perioperative Outcomes

Choline and Iron Deficiency

Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Meals to Improve Absorption of Iron Supplements

RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone

Multi-Center Study of Iron Overload: Pilot Study

Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality

Iron Absorption and Exercise

Effera Dose Response: Women's Health

The Benefits of a Preoperative Anemia Management Program

Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)

Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

Iron Indices and Intravenous Ferumoxytol: Time to Steady State

Imaging Neuroinflammation in Epilepsy With Ferumoxytol MRI

Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)

The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin Levels

Iron Status in Women of Reproductive Age Reproductive Age

Early Neurovascular Adaptations in Aging Women